Q BioMed Adds Boston University's Dr. Helen Tager-Flusberg to Advisory Committee
Q BioMed Inc., a biotechnology acceleration company, announced today that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is being tested for pediatric developmental nonverbal disorder in toddlers within the autism spectrum disorders.
View full press release